The U.S. FDA device center’s guidance agenda for fiscal 2026 is the classic case of something old and something new, but what ...

Nanyang Biologics Pte. Ltd. has entered a $1.5 billion business combination agreement with RF Acquisition Corp II, a ...

Bacterial resistance remains one of the biggest obstacles to antibiotic efficacy and spurs the constant search for ...

Like a scene from a movie, a British beauty influencer and a German disabled war veteran could provide just the spark that ...

The U.S. FDA has approved the priority sNDA for a new first-line maintenance therapy in extensive-stage small-cell lung ...

Genetic mutations are the primary cause of most rare diseases. Although each condition affects a small fraction of the ...

With a new drug available to slow the progression of type 1 diabetes, Sanofi SA is partnering with two med-tech companies to ...

Pharma companies are collaborating to boost the power of artificial intelligence (AI) in drug discovery by allowing access to ...

Pop Biotechnologies Inc. has been awarded a $2.46 million grant by the National Institutes of Health (NIH) to pursue ...

Medtronic plc’s Brainsense adaptive deep brain stimulation system has been shown to be tolerable, effective and safe for long ...

Novo Nordisk A/S terminated its global licensing deal with Japan’s Heartseed Inc. for its allogeneic induced pluripotent stem ...

CSPC Pharmaceutical Group Ltd. has obtained clearance from China’s National Medical Products Administration (NMPA) to conduct ...